Work

ABCL-536: Complete Metabolic Responses to Checkpoint Inhibitor Therapy in Patients With PD-L1–Enriched Relapsed/Refractory DLBCL Ineligible for Intensive Therapy: A Real-World Case Series From an LMIC Tertiary Center

Year: 2026

Type: article

Study design: Case Report

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)02570-x

Authors: Jerryes Pious Wisely, Ashutosh Jain, Punam Rabha, Kilitoli Chophy, Narendra Bhardwaj, Brij Bhushan Tyagi, Vinod Raina

Institution: Fortis Memorial Research Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204728153

FWCI:

Cites:

Cited by:

Related to: 10